News

Reporter on the road: spark- how it all started in Silicon Valley
17 August 2018
While Silicon Valley is recognized for its tech & internet industry, its historical role in life sciences is maybe less well-known. In the ‘70s, Stanley Cohen of Stanford and Herbert Boyer of UCSF started tinkering with bacterial plasmids in their labs.
The virtues of early diagnosis a window of opportunity in spondyloarthritis
17 August 2018
Spondyloarthritis is one of the most common types of chronic joint inflammation. Studies by VIB-UGent suggest that when diagnosed and treated early, disease progression may be halted to a point where patients no longer need medication nor suffer symptoms
New insights in cell death in plants might generate new leads for weed control
14 August 2018
Some plants like the giant sequoia trees can grow into the “Largest Living Things on Earth”. Ironically, most of a tree’s biomass is actually not alive, but is formed by persistent cell corpses that are collectively called wood.
Researchers show that transcription factors cooperate to cause leukemia
13 August 2018
A group of scientists led by prof. Jan Cools (VIB-KU Leuven Center for Cancer Biology) has expanded scientific understanding of the development of T-ALL, an aggressive form of leukemia. Their results are published in the academic journal Cancer Cell.
Tech watch highlights
11 August 2018
Evaluation of the fox white 1.0 biomolecular measurementtechnology platform - Whole human dna sequencing at VIB on the promethion from oxford nanopore technologies - VIB single cell accelerator
Quickscan-2018-II
10 August 2018
VIB's scientific publications second quarter 2018
Ruling of European Court of Justice puts sustainable agriculture in Europe at risk
31 July 2018
Wherever you look around the world, the gradual improvement of people's health and living standards has always been accompanied by a systematic optimization of the production of safe, nutritious and affordable food.
Launch of Single Cell Accelerator drives VIB to forefront of single cell research
25 July 2018
This new program will run through VIB’s Tech Watch initiative and will inject additional funding & technological support in emerging single cell technologies. This will enable VIB to establish its position at the forefront of this moving research field.
A study by Thomas Voets and his team heats up our understanding of ion channels
19 July 2018
The teams of Thomas Voets (VIB-KU Leuven Center for Brain & Disease Research) and Joris Vriens (KU Leuven) have successfully published a boundary-pushing paper on mammalian heat-sensing channels in the high-impact journal Nature.
Molecular culprits of protein aggregation in ALS and FTLD
18 July 2018
Using a newly developed fruit fly model, researchers led by prof. Ludo Van Den Bosch (VIB-KU Leuven) have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
Biocartis launches innovative Idylla™ MSI Assay
17 July 2018
Idylla™ MSI Assay further strengthens Biocartis’ test menu and offers opportunities to enter the immuno-oncology testing market
New weapon against chemotherapy-resistant cancer cells discovered
16 July 2018
Research from VIB, Ghent University and the University of Antwerp, led by the brothers Tom and Wim Vanden Berghe, has led to the discovery of a new molecular mechanism that can kill cancer cells in mice.
New research reveals central role of the hippocampus in instructing the neocortex in spatial navigation and memory
16 July 2018
A research collaboration between the University of Lethbridge and NERF, VIB-KU Leuven-imec, provided new insight into how the brain learns about the environment and why the hippocampus, a key part of the brain, is so important in this process.
New insights to improve targeted therapies in advanced melanoma
12 July 2018
A team of scientists led by Jean-Christophe Marine (VIB-KU Leuven Center for Cancer Biology) has demonstrated that melanoma cells are capable of adapting their behavior when exposed to therapy to become highly resilient.
Scientists create a complete atlas of lung tumor cells
9 July 2018
Researchers from VIB, Leuven University and University Hospital Leuven studied thousands of healthy and cancerous lung cells to create the first comprehensive atlas of lung tumor cells.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS